| Literature DB >> 35210347 |
Xiaorong Tang1, Xiaoshuang Shi2,3, Hong Zhao3,4, Liming Lu1, Ze Chen1, Yixuan Feng3, Lanping Liu5, Ruihua Duan6, Pingping Zhang5, Yuqin Xu3, Shuo Cui3, Fen Gong6, Jingwen Fei5, Neng-Gui Xu1, Xianghong Jing7, Gordon Guyatt8,9, Yu-Qing Zhang7,8,10,11.
Abstract
OBJECTIVE: To systematically summarise acupuncture-related Clinical Practice Guidelines (CPGs)'s clinical and methodological characteristics and critically appraise their methodology quality.Entities:
Keywords: complementary medicine; health economics; public health
Mesh:
Year: 2022 PMID: 35210347 PMCID: PMC8883258 DOI: 10.1136/bmjopen-2021-058834
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1The Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram. CPG, clinical practice guideline.
Characteristics of 133 included CPG in the study
| Variable | N (%) |
|
| |
| International | 3 (2.3) |
| America | 49 (36.8) |
| Asia | 44 (33.1) |
| Europe | 31 (23.3) |
| Oceania | 6 (4.5) |
|
| |
| Comprehensive CPG | 89 (66.9) |
| T&CM CPG | 13 (9.8) |
| Acupuncture-specific CPG | 31 (23.3) |
|
| |
| Comprehensive CPG | 46 (34.6) |
| T&CM CPG | 7 (5.3) |
| Acupuncture-specific CPG | 12 (9.0) |
|
| |
| Treatment | 129 (97.0) |
| Prevention | 17 (12.8) |
|
| |
| Healthcare provider | 127 (95.5) |
| Policy-maker | 9 (6.8) |
| Patient | 39 (29.3) |
|
| |
| Reported | 69 (51.9) |
| Not reported | 64 (48.1) |
|
| |
| Reported | 59 (44.4) |
| Not reported | 74 (55.6) |
*One CPG can contribute to more than one category.
CPG, clinical practice guidelines; GRADE, Grading of Recommendations Assessment, Development and Evaluation; T&CM, traditional and complementary medicine.
Figure 2A multidimensional plot for acupuncture guidelines and recommendations’ quantity, methodological rigour and distribution of therapeutic areas. Each pie represents a therapeutic area. (1) Pie size: number of CPGs (larger=more studies). (2) Pie colour: direction of recommendation (green: recommend for, red: recommend against; pink: did not make a recommendation). CPG, clinical practice guideline.
The methodological quality of 133 CPGs (%)
| Domain | Comprehensive CPGs | T&CM CPGs | Acupuncture-specific CPGs | Total | P value |
| Scope and purpose | 74.0 | 66.0 | 95.2 | 78.4 | 0.386 |
| Stakeholder involvement | 49.8 | 32.7 | 67.8 | 50.1 | |
| Rigour of development | 51.6 | 45.9 | 71.3 | 56.3 | |
| Clarity of presentation | 75.2 | 68.2 | 79.8 | 74.4 | |
| Application | 32.1 | 22.4 | 35.4 | 30.0 | |
| Editorial independence | 53.4 | 48.7 | 33.2 | 45.1 |
CPG, clinical practice guidelines; T&CM, traditional and complementary medicine.
Evidence supports acupuncture recommendations
| Variable | N (%) |
| SR or meta-analysis | 135 (31.2) |
| RCT or CCT | 250 (57.7) |
| Observational studies | 114 (26.3) |
| Narrative review | 36 (8.3) |
| Expert consensus | 24 (5.5) |
| Chinese classic texts/ Textbook | 4 (0.9) |
| Not reported | 47 (10.9) |
|
| |
| Comprehensive CPG | 46 (40.7) |
| T&CM CPG | 24 (36.3) |
| Acupuncture-specific CPG | 244 (96.1) |
|
| |
| High | 5 (1.6) |
| Moderate | 33 (10.5) |
| Low | 105 (33.4) |
| Very low | 157 (50.0) |
| Not reported | 14 (4.5) |
*One recommendation can contribute to more than one category.
development, and evaluation, CCT, controlled clinical trial; CPG, clinical practice guidelines; GRADE, Grading of Recommendations Assessment, Development and Evaluation; RCT, randomised controlled trial; SR, systematic review; T&CM, traditional and complementary medicine.
Direction and strength of acupuncture recommendations
| Variable | N (%) |
|
| |
| In favour | 380 (87.8) |
| Against | 28 (6.4) |
| Did not make recommendations | 25 (5.8) |
|
| |
|
| 131 (43.2) |
| High and moderate certainty of the evidence | 26 (19.8) |
| Low and very low certainty of the evidence | 104 (79.4) |
| Not reported | 1 (0.8) |
|
| 152 (50.2) |
| High and moderate certainty of the evidence | 10 (6.6) |
| Low and very low certainty of the evidence | 135 (88.8) |
| Not reported | 7 (4.6) |
|
| 20 (6.6) |
GRADE, Grading of Recommendations Assessment, Development and Evaluation.
Details of acupuncture interventions in the recommendations and remarks
| Description of acupuncture intervention | N (%) | P value | ||
| Comprehensive CPGs | T&CM CPGs | Acupuncture-specific CPGs | ||
|
| ||||
| Manual acupuncture | 57 (50.4) | 37 (56.1) | 121 (47.6) | <0.001 |
| Electroacupuncture | 13 (11.5) | 13 (19.7) | 42 (16.5) | |
| Acupressure | 19 (16.8) | 2 (3.0) | 5 (2.0) | |
| Moxibustion, warm needling, fire needling | 6 (5.3) | 12 (18.2) | 55 (21.7) | |
| Other† | 26 (23.0) | 14 (21.2) | 97 (38.2) | |
| Not reported | 44 (38.9) | 14 (21.2) | 15 (5.9) | |
|
| ||||
| Alone | 100 (88.5) | 42 (63.6) | 192 (75.6) | 0.006 |
| With conventional medicine | 4 (3.5) | 9 (13.6) | 16 (6.3) | |
| With Chinese herbal medicine | 2 (1.8) | 4 (6.1) | 5 (2.0) | |
| With Non-pharmacological interventions | 10 (8.8) | 14 (21.2) | 41 (16.1) | |
|
| ||||
| Reported | 6 (5.3) | 20 (30.3) | 206 (81.1) | <0.001 |
| Not reported | 107 (94.7) | 46 (69.7) | 48 (18.9) | |
|
| ||||
| Reported | 0 (0.0) | 1 (1.5) | 39 (15.4) | <0.001 |
| Not reported | 113 (100.0) | 65 (98.5) | 215 (84.6) | |
|
| ||||
| Reported | 0 (0.0) | 0 (0.0) | 5 (2.0) | 0.177 |
| Not reported | 113 (100.0) | 66 (100.0) | 249 (98.0) | |
*One recommendation can contribute to more than one category.
†Include laser acupuncture, microsystem acupuncture, thread-embedding therapy, medicine acicula, point injection, transcutaneous electrical nerve, acupoint paste; magnetic acupuncture, blood-letting therapy, acupotomy.
CPG, clinical practice guidelines; T&CM, traditional and complementary medicine.